NOT-EB-18-023: Notice of NIBIB's Participation in NOT-TR-18-027 "Notice of Availability of Administrative Supplements for Tissue Chip Consortium Awardees: Development of Tissue Chips to Model Nociception, Opioid Addiction and Overdose"

Notice of NIBIB's Participation in NOT-TR-18-027 "Notice of Availability of Administrative Supplements for Tissue Chip Consortium Awardees: Development of Tissue Chips to Model Nociception, Opioid Addiction and Overdose"

Notice Number: NOT-EB-18-023

Key Dates
Release Date: August 8, 2018

Related Announcements
NOT-TR-18-027

Issued by
National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Purpose

The purpose of this Notice is to inform potential applicants that the National Institute of Biomedical Imaging and Bioengineering (NIBIB) will participate, effective immediately, in NOT-TR-18-027 "Notice of Availability of Administrative Supplements for Tissue Chip Consortium Awardees: Development of Tissue Chips to Model Nociception, Opioid Addiction and Overdose".

The following changes and updates are made to NOT-TR-18-027 (shown in italics) to reflect NIBIB participation in this FOA.

National Institutes of Health (NIH)

National Heart, Lung, and Blood Institute (NHLBI)

National Institute on Dental and Craniofacial Research (NIDCR)

National Institute of Neurological Disorders and Stroke (NINDS)

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

All other aspects of this Notice remain the same.

Inquiries

Please direct all inquiries to:

eila Selimovic, Ph.D.

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Telephone: 301-451-4577

Email: Seila.Selimovic@nih.gov